EGFR and non-small cell lung carcinoma: Esposito et al. reported that CL4, an anti-EGFR 2′-fluoro pyrimidine RNA aptamer, inhibited EGFR-mediated signal pathways, induced apoptosis, and inhibited tumor growth in a mouse xenograft model of human non-small-cell lung cancer (NSCLC) [7].